Skip to Content

R530 (Divalproex sodium delayed-release 250 mg)

Pill with imprint R530 is White, Elliptical / Oval and has been identified as Divalproex sodium delayed-release 250 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for R530

Divalproex sodium delayed-release

Imprint:
R530
Strength:
250 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
acetone
hypromellose
hypromellose phthalate (31% phthalate, 40 cst)
isopropyl alcohol
methylene chloride
microcrystalline cellulose
povidone
corn starch
silicon dioxide
magnesium silicate
titanium dioxide
vanillin
shellac
ferrosoferric oxide
butyl alcohol
soya lecithin
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide